DUBLIN--(BUSINESS WIRE)--The "Cosmetic Surgery Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
The global cosmetic surgery market is expected to grow from $39.01 billion in 2021 to $40.67 billion in 2022 at a compound annual growth rate (CAGR) of 4.3%. The cosmetic surgery market is expected to grow to $48.84 billion in 2026 at a CAGR of 4.7%.
North America was the largest region in the cosmetic surgery market in 2021 and is expected to be the fastest-growing region in the forecast period. The regions covered in the cosmetic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The rising number of cosmetic surgery hospitals is driving the growth of the cosmetic surgery market. Cosmetic surgery is done to improve a person's appearance by repairing the damaged areas of skin, and removal of wrinkles or blemishes. The growing social and cultural influences such as media, fashion, and film industry, peer pressure for appearance and attractiveness, and shifting dimensions of beauty have raised the number of cosmetic surgery hospitals all over the world.
For example, in 2020, according to The American Society of Plastic Surgeons, a plastic surgery specialty organization, $16.7 billion was spent on cosmetic procedures in the U.S., 15.6 million cosmetic procedures were completed, out of which 2.3 million were cosmetic surgical procedures and 13.2 million cosmetic surgeries were minimally-invasive procedures, 6.8 million included reconstructive procedures. The increasing number of cosmetic surgery has raised the number of hospitals, free-standing ambulatory surgical facilities, and office premises to conduct cosmetic surgery procedures.
The Botulinum Toxin is a key trend gaining popularity in the cosmetic surgery market. The increasing demand for cosmetic surgeries and minimally invasive procedures has increased in the past few years. Botulinum Toxin injections also known as Botox are used to improve appearance by relaxing muscles that cause wrinkles. These injections are also used in treating medical conditions like eye problems, migraines, hyperhidrosis, and overactive bladder. For instance, in 2021, a study, from the American Society of Plastic Surgeons, found that Botox injections became the most popular non-invasive cosmetic procedure in 2020, with 4.4 million procedures performed in 2019.
Scope
Markets Covered:1) By Procedure Type: Surgical Procedures; Non-Surgical Procedures; Other Procedures
2) By Provider: Spas And Cosmetic Surgery Centers; Hospitals And Specialty Clinics
3) By Gender: Male; Female
4) By Application: Liposuction; Eyelid And Nose Surgery; Body Contouring; Face Reconstruction; Cosmetic Implants; Other Applications
5) By End-User: Hospitals; Surgical Centers; Other End-Users
Key Topics Covered:
1. Executive Summary
2. Cosmetic Surgery Market Characteristics
3. Cosmetic Surgery Market Trends And Strategies
4. Impact Of COVID-19 On Cosmetic Surgery
5. Cosmetic Surgery Market Size And Growth
6. Cosmetic Surgery Market Segmentation
7. Cosmetic Surgery Market Regional And Country Analysis
8. Asia-Pacific Cosmetic Surgery Market
9. China Cosmetic Surgery Market
10. India Cosmetic Surgery Market
11. Japan Cosmetic Surgery Market
12. Australia Cosmetic Surgery Market
13. Indonesia Cosmetic Surgery Market
14. South Korea Cosmetic Surgery Market
15. Western Europe Cosmetic Surgery Market
16. UK Cosmetic Surgery Market
17. Germany Cosmetic Surgery Market
18. France Cosmetic Surgery Market
19. Eastern Europe Cosmetic Surgery Market
20. Russia Cosmetic Surgery Market
21. North America Cosmetic Surgery Market
22. USA Cosmetic Surgery Market
23. South America Cosmetic Surgery Market
24. Brazil Cosmetic Surgery Market
25. Middle East Cosmetic Surgery Market
26. Africa Cosmetic Surgery Market
27. Cosmetic Surgery Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Cosmetic Surgery Market
29. Cosmetic Surgery Market Future Outlook and Potential Analysis
30. Appendix
Companies Mentioned
- AbbVie
- Cynosure
- Alma Laser
- Bausch Health Companies Inc.
- Galderma SA
- Merz Pharma GmbH & Co. KGaA
- Evolus Inc.
- RevanceGalderma
- Lumenis
- Solta Medical
- Syneron Candela
- Sinclair Pharma plc.
- Syneron
- Teoxane Laboratories
- Vital Esthetique
- Polytech Health & Aesthetics GmbH
- GC Aesthetics
- HansBiomed Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/258eg
